Companies · Biotechnology

Sentire Medical Systems, Inc.

PALM BEACH GARDENS · Biotechnology

Diligence memoA one-page analyst read on Sentire Medical Systems, Inc. — recommendation, valuation, rhythm, risks.
$1.8M
Total raised · real
2
Rounds
1.9×
Latest step-up
Top 75%
Sector rank · raised
Seed
Latest stage · inferred · Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Sentire Medical Systems, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.55× the median modeled value of Seed Biotechnology companies in 2025–2027 (99 peers) — value vs value, same stage and era.
  • Issuer reports $0–$1M revenue while modeled below niche peers.
Active
  • Last raise 7 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Sentire Medical Systems, Inc. is one of 4291 Biotechnology companies tracked from PALM BEACH GARDENS. By capital raised it ranks in the long tail (ahead of 26% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 506(c)
Reg D exemption
9
Investors (latest)
2025-12-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2018-01-08 Raised $600K (real) Modeled valuation $33M (est)$600K$33MPre-Seed2018Seed · 2025-12-15 Raised $1.2M (real) Modeled valuation $2.5M (est)$1.2M$2.5MSeed2025+$1.2MCumulative $1.8M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$600K · 2018
Seed$1.2M · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$2.5M
Base estimate est.
$841K
Conservative case
$4.5M
Upside case
$5.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $33.1M · 2018-01-082018Seed · modeled $2.5M · 2025-12-152025
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
0.5 yr
Elapsed time used
0.5 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
95 mo
Avg between rounds
$223K/yr
Capital velocity
8.5 yr
On record since
2018
First round
2
Rounds on file
How it compares to the market

Benchmarked against 4291 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.2× of median
This company$1.8M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.7× of median
This company$1.2M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$2.5M
Sector median$64.2M

Raised more than 26% of sector peers (real $). Modeled value above 6% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #74 of 99.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0MCapital raised (log)Carna Inc. · Seed Raised $3.4M · modeled $12.4M (est)NRX Pharmaceuticals, Inc. · Seed Raised $3.5M · modeled $12.3M (est)Vicora, Inc. · Seed Raised $3.4M · modeled $11.9M (est)MH3D, Inc. · Seed Raised $3.3M · modeled $11.9M (est)Oral Genome Corp. · Seed Raised $3.1M · modeled $11.2M (est)Synlico Inc. · Seed Raised $5.2M · modeled $10.1M (est)Auxilium Biotechnologies Inc. · Seed Raised $7.2M · modeled $9.7M (est)Silexion Therapeutics Corp · Seed Raised $3.6M · modeled $9.6M (est)Bodark Investment Group LP · Seed Raised $3.3M · modeled $9.4M (est)Sower Solas I Sidecar III, LLC · Seed Raised $3.5M · modeled $9.3M (est)Sift Biosciences, Inc. · Seed Raised $3.8M · modeled $8.4M (est)SiVEC Biotechnologies, Inc. · Seed Raised $3.3M · modeled $8.4M (est)Sentire Medical Systems, Inc. (this company) Raised $1.8M · modeled $2.5M (est)Sentire Medical Systems, Inc.
CompanyStageRaised · realValue · estvs peer med.
Carna Inc.Seed$3.4M$12.4M2.72×
NRX Pharmaceuticals, Inc.Seed$3.5M$12.3M2.70×
Vicora, Inc.Seed$3.4M$11.9M2.61×
MH3D, Inc.Seed$3.3M$11.9M2.61×
Oral Genome Corp.Seed$3.1M$11.2M2.45×
Synlico Inc.Seed$5.2M$10.1M2.22×
Auxilium Biotechnologies Inc.Seed$7.2M$9.7M2.13×
Silexion Therapeutics CorpSeed$3.6M$9.6M2.10×
Bodark Investment Group LPSeed$3.3M$9.4M2.06×
Sower Solas I Sidecar III, LLCSeed$3.5M$9.3M2.05×
Sift Biosciences, Inc.Seed$3.8M$8.4M1.85×
SiVEC Biotechnologies, Inc.Seed$3.3M$8.4M1.85×
Sentire Medical Systems, Inc. this companySeed$1.8M$2.5M0.55×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$600K2018-01-08$3.3M$33.1M90%
Seed$1.2M2025-12-15$5.8M$2.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$600K2018-01-08
    • First recorded raise — entered as Pre-Seed.
    • 3 investors on this round.
  2. Seed$1.2M2025-12-15
    • Raised again after 95 mo — slower than the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 9 investors on this round.
Intelligence
2033 ~Q4
Modeled next raise · ~95mo cadence
$2.3M
Modeled next size est.range $1.5M$3.6M
1.9×
Last step-up
$223K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Peng Cheng2 other2018-01
David Krasne1 other2018-01
Jonathan Diamond1 other2018-01
Registry & provenance

Sentire Medical Systems, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1728443
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
QuanDx, Inc.BiotechnologySeed$4.3M$133.2Mnetwork1 shared operator · same sector · same stage
Ceretype Neuromedicine, Inc.BiotechnologySeed$1.8M$1.8Msame sector · same stage
Akelos, Inc.BiotechnologySeed$1.8M$2.8Msame sector · same stage
SeqOnce BioSciences, Inc.BiotechnologySeed$1.9M$3.6Msame sector · same stage
Twister Biotech, Inc.BiotechnologySeed$1.6M$3.9Msame sector · same stage
Greyson Internatonal IncBiotechnologySeed$1.6M$4.4Msame sector · same stage
MOAT BIOTECHNOLOGY CorpBiotechnologySeed$1.6M$1.1Msame sector · same stage
Resolute Science, Inc.BiotechnologySeed$1.6M$4.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Senti Biosciences, Inc.BiotechnologySeries B$221.8M91%
Sentrimed, Inc.BiotechnologyPre-Seed$2.8M89%
SentreHEART IncBiotechnologySeries B$992.2M89%
SentryAg Inc.BiotechnologySeed$34.5M87%
Sendero Biotechnology, Inc.BiotechnologySeries A$69.1M86%
TellBio, Inc.BiotechnologySeries A$4.8M86%
Recros Medica, Inc.BiotechnologySeries A$149.0M85%
Santiste Medical Inc.BiotechnologyPre-Seed$10.3M85%
Frequently asked
How much funding has Sentire Medical Systems, Inc. raised?
Sentire Medical Systems, Inc. has raised approximately $1.8M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Sentire Medical Systems, Inc.'s estimated valuation?
Provath's modeled valuation for Sentire Medical Systems, Inc. is approximately $2.5M (modeled range $841K–$4.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Sentire Medical Systems, Inc. at?
Sentire Medical Systems, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Dec 15.
What does Sentire Medical Systems, Inc. do and where is it based?
Sentire Medical Systems, Inc. operates in the Biotechnology sector, based in PALM BEACH GARDENS.
Explore related

See where Sentire Medical Systems, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Sentire Medical Systems, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.